ReadCoor

BiotechnologySeries BCambridge, USreadcoor.com

Latest round

Series B

Last raised

Oct 2019

Total raised

$50M

Investors

4

About ReadCoor

Founded in 2016 and based in Massachusetts, US, ReadCoor, Inc. operates as a provider of panomic spatial sequencing platform that enables researchers to perform RNA sequencing and provides spatial image data. The company's platform operates fluorescent in situ sequencing (FISSEQ), a fundamental technology that helps clients to access clinical insight for the treatment for cancer, immuno-oncology, infectious diseases, neurological and neuromuscular diseases, brain function and cognitive disorders.

Who invested in ReadCoor

4 investors across 2 rounds

See all investors in ReadCoor

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Oct 3, 2019

    Amount

    $27M

    Investors

    Locked

  2. Series A

    Sep 16, 2016

    Amount

    $23M

    Investors

    Locked

Questions about ReadCoor

Who invested in ReadCoor?

ReadCoor has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has ReadCoor raised?

ReadCoor has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did ReadCoor last raise money?

ReadCoor's most recent round on record is a Series B, in Oct 2019.

What does ReadCoor do?

Founded in 2016 and based in Massachusetts, US, ReadCoor, Inc.

Where is ReadCoor headquartered?

ReadCoor is headquartered in Cambridge, US.

Which VCs invest in companies like ReadCoor?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at ReadCoor's stage. Their profiles are linked below.

Raising like ReadCoor? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.